Bright Minds Biosciences
Biotechnology company creating the next generation of psychedelics to treat mental health disorders
Ian McDonald and Dr. Gideon Shapiro at the Benzinga Global Small Cap Conference
Revati Shreeniwas | Fibromyalgia
Revati Shreeniwas | Neuropathy
Revati Shreeniwas | Neuropsychiatry
Revati Shreeniwas on Epilepsy
Meet Revati Shreeniwas, Chief Medical Officer
Revati Shreeniwas on Drug Epidemic
Bright Minds Story (full version)
Bright Minds Story
Is Big Pharma Interested in Psychedelic Medicine?
Bright Minds Co-founder & Lead Scientist Talks about IP Protection
How is Bright Minds Creating Value for Its Shareholders?
Psilocybin/Psilocin Binding to 5-HT2A Receptor (Molecular Dynamics)
Dr. Alan Kozikowski Talks about New Pain Management Drugs
Dr. Alan Kozikowski Talks About His Education and Career
Dr. Alan Kozikowski on How He Designs New Psilocybin Drug to Treat Depression